Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Diabetes"
DOI: 10.1111/pedi.13312
Abstract: Highly variable insulin sensitivity, susceptibility to hypoglycemia and inability to effectively communicate hypoglycemic symptoms pose significant challenges for young children with type 1 diabetes (T1D). Herein, outcomes during clinical MiniMed™ 670G system use were evaluated… read more here.
Keywords: 670g system; outcomes children; type diabetes; minimed 670g ... See more keywords
Real-World Data from the MiniMed™ 670G System Commercial Launch—The First 1,052 Patients Using the System for Three Months
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-994-p
Abstract: The Medtronic MiniMed™ 670G hybrid closed-loop system with SmartGuard™ technology was released for commercial use in the U.S. in March 2017. Sensor glucose (SG) and device utilization data from the initial open-loop Manual Mode and… read more here.
Keywords: 670g system; system; self medtronic; patients using ... See more keywords
1066-P: Improvement in Time-in-Range (TIR) with Real-Life Use of Hybrid Closed-Loop System in Patients with Type 1 Diabetes (T1D)
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes"
DOI: 10.2337/db19-1066-p
Abstract: Newer metrics like TIR are gaining momentum for measurement of glycemic control. The Medtronic 670G is the first commercial hybrid closed-loop (HCL) system for the management of T1D. We conducted a single-center retrospective chart review… read more here.
Keywords: system patients; system; closed loop; 670g system ... See more keywords
2405-PUB: Minimed 640G vs. Minimed 670G, a Comparison in Children and Adolescents with Diabetes Type 1
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes"
DOI: 10.2337/db19-2405-pub
Abstract: Introduction: After a long lead-in period, artificial pancreas (AP) technology is well on its way to revolutionizing the treatment of diabetes, but no AP is currently approved. Recently data about the use of a hybrid… read more here.
Keywords: system; time; using 640g; minimed 670g ... See more keywords